alpha-Adrenergic regulation of human renal function

Area of Science:

• Pharmacology
• Renal Physiology
• Adrenoceptor Signaling

Background:

• Six human alpha-adrenoceptor subtypes (alpha 1A, 1D, 2A, 2C) have been identified.
• Human kidney primarily expresses alpha-2A adrenoceptors at the protein level.
• Presynaptic alpha-2C adrenoceptors inhibit noradrenaline release in the human kidney.

Purpose of the Study:

• To investigate the role of different alpha-adrenoceptor subtypes in regulating renal function.
• To determine whether alpha-1 or alpha-2 adrenoceptors mediate tonic renal vasoconstriction and renin release.

Main Methods:

• Infusion of selective and nonselective alpha-adrenoceptor antagonists (phentolamine, yohimbine, doxazosin) into the renal artery.
• Measurement of renal blood flow and renin release during diagnostic renal angiography in hypertensive patients.

Main Results:

• Intrarenal infusion of phentolamine and yohimbine increased renal blood flow and renin release.
• Doxazosin, an alpha-1 adrenoceptor antagonist, did not significantly affect renal blood flow or renin release.
• Alpha-2 adrenoceptors, but not alpha-1, appear to mediate tonic renal vasoconstriction and renin release inhibition.

Conclusions:

• Alpha-2 adrenoceptors play a dominant role in tonic regulation of renal hemodynamics and renin release in humans.
• The complexity of systemic drug effects necessitates empirical evaluation for specific patient populations.
• Further research is needed to elucidate the precise mechanisms and clinical implications of alpha-adrenoceptor modulation in the kidney.